ESMO 2022 | Role of patient advocacy in clinical trial design

Lydia Makaroff, PhD, Fight Bladder Cancer and World Bladder Cancer Patient Coalition, Cambridge, UK, discusses the importance of including patient advocacy groups in the design of clinical trials. Patient advocacy groups can provide unique insights into patient experience and quality of life, which are crucial metrics to include in many clinical trials. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.